This study by Al-Zirqi et al. (AJOG, 2017) sought to determine risk factors for complete uterine rupture during childbirth.
Population-Based Study
1,317,967 women without previous C-section and 57,859 with previous C-section were surveyed. Of the women without previous C-section, 51 experienced complete uterine rupture, and of the women with previous C-section, 122 experienced complete uterine rupture. Regardless of previous history of C-section, the largest risk factor for complete uterine rupture was labor induction followed with prostaglandins and oxytocin. Other risk factors in both groups included labor augmentation with oxytocin alone, antepartum fetal death, and previous first-trimester miscarriage. In women who had a previous C-section, risk increased in those women who had experienced severe postpartum hemorrhage and when the interdelivery interval was <16 months.
Risk factors for complete uterine rupture
Please log in to access OBGFirst and the 2T Ultrasound Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
